Clover Historical Financial Ratios
CLOV Stock | USD 3.34 0.07 2.05% |
Clover Health is presently reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 4.75 or Days Sales Outstanding of 36.78 will help investors to properly organize and evaluate Clover Health Investments financial condition quickly.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clover Health Investments. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. About Clover Financial Ratios Analysis
Clover Health InvestmentsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Clover Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Clover financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Clover Health history.
Clover Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Clover Health Investments stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Clover Health sales, a figure that is much harder to manipulate than other Clover Health Investments multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Clover Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Clover Health Investments current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clover Health Investments. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. At this time, Clover Health's Sales General And Administrative To Revenue is fairly stable compared to the past year. Capex To Revenue is likely to climb to 0 in 2025, whereas Stock Based Compensation To Revenue is likely to drop 0.06 in 2025.
2022 | 2023 | 2024 | 2025 (projected) | Net Debt To EBITDA | 0.39 | 0.57 | 4.33 | 4.55 | Intangibles To Total Assets | 0.0247 | 0.005239 | 0.005149 | 0.004891 |
Clover Health fundamentals Correlations
Click cells to compare fundamentals
Clover Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Clover Health fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Price To Sales Ratio | 10.08 | 1.19 | 0.4 | 0.36 | 1.13 | 1.07 | |
Ptb Ratio | (11.93) | 3.25 | 1.27 | 1.6 | 4.52 | 4.75 | |
Book Value Per Share | (4.4E-5) | (1.41) | 1.15 | 0.73 | 0.59 | 0.7 | |
Free Cash Flow Yield | (4.31E-4) | (0.16) | (0.47) | (0.25) | 0.0216 | 0.0226 | |
Operating Cash Flow Per Share | (0.005507) | (0.6) | (0.43) | (0.24) | 0.0711 | 0.0747 | |
Stock Based Compensation To Revenue | 0.007141 | 0.0105 | 0.11 | 0.15 | 0.0834 | 0.0557 | |
Capex To Depreciation | 1.25 | 0.58 | 3.76 | 0.23 | 1.17 | 1.58 | |
Pb Ratio | (11.93) | 3.25 | 1.27 | 1.6 | 4.52 | 4.75 | |
Ev To Sales | 10.04 | 1.01 | 0.31 | 0.27 | 0.98 | 0.93 | |
Free Cash Flow Per Share | (0.00722) | (0.6) | (0.44) | (0.24) | 0.0679 | 0.0713 | |
Roic | (0.11) | (1.1) | (0.78) | (0.66) | (0.12) | (0.13) | |
Net Income Per Share | (0.34) | (1.25) | (0.71) | (0.44) | (0.0878) | (0.0922) | |
Sales General And Administrative To Revenue | 0.41 | 0.29 | 0.3 | 0.44 | 0.35 | 0.39 | |
Capex To Revenue | 0.00103 | 4.91E-4 | 0.004074 | 4.63E-4 | 0.001135 | 0.001964 | |
Cash Per Share | 0.37 | 1.31 | 0.7 | 0.5 | 0.45 | 0.84 | |
Pocfratio | (3.0K) | (6.2) | (2.17) | (3.96) | 44.3 | 46.51 | |
Interest Coverage | (1.62) | (37.67) | (210.32) | (29.3K) | (33.7K) | (32.0K) | |
Capex To Operating Cash Flow | (0.31) | (0.002561) | (0.0219) | (0.00504) | 0.0447 | 0.0469 | |
Pfcf Ratio | (2.3K) | (6.19) | (2.12) | (3.94) | 46.37 | 48.69 | |
Income Quality | 0.33 | 0.48 | 0.6 | 0.54 | (0.81) | (0.77) | |
Roe | 0.24 | (1.09) | (0.98) | (0.74) | (0.13) | (0.12) | |
Ev To Operating Cash Flow | (3.0K) | (5.24) | (1.69) | (2.94) | 38.71 | 40.65 | |
Pe Ratio | (49.73) | (2.98) | (1.3) | (2.15) | (35.89) | (34.09) | |
Return On Tangible Assets | (0.52) | (0.62) | (0.43) | (0.38) | (0.0744) | (0.0707) | |
Ev To Free Cash Flow | (2.3K) | (5.23) | (1.65) | (2.93) | 40.52 | 42.55 | |
Earnings Yield | (0.0201) | (0.34) | (0.77) | (0.46) | (0.0279) | (0.0293) | |
Intangibles To Total Assets | 0.0158 | 0.004452 | 0.0247 | 0.005239 | 0.005149 | 0.004891 | |
Net Debt To E B I T D A | 0.35 | 0.48 | 0.39 | 0.57 | 4.33 | 4.55 | |
Current Ratio | 0.83 | 2.02 | 1.42 | 1.64 | 1.61 | 1.53 | |
Tangible Book Value Per Share | (0.0105) | (1.42) | 1.14 | 0.69 | 0.59 | 0.72 | |
Shareholders Equity Per Share | (4.4E-5) | (1.41) | 1.15 | 0.73 | 0.59 | 0.7 | |
Debt To Equity | (0.001418) | 0.0516 | 0.0169 | 0.0163 | 0.0147 | 0.0154 | |
Capex Per Share | 0.001713 | 0.001536 | 0.00938 | 0.001211 | 0.003175 | 0.003017 | |
Graham Net Net | 0.17 | (1.95) | 0.44 | (0.14) | 0.0908 | 0.11 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clover Stock Analysis
When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.